“There has to also be money side to this whole
“There has to also be money side to this whole fiasco.”
You got that right. Gilead made $8.4 billion dollars on remdesivir just from 2020-2021. Jeff Murray was involved in Gilead’s Descovy approval. The BP relationships were forged. I doubt he uttered “I hate them” behind the scenes with the Gilead deliberations.
As entertaining and enraging as this all is I think Jay is not distracted and working through options. Partnership is the power play that would be non-dilutive and obtains the imprimatur of the big boys club that results in a true price inflection. We haven’t heard much likely because this is all ongoing behind closed doors. The one two punch would be a dual announcement of funding from partnership for one of the indications and a redirection of a mere 2-3 million to activate the HIV inflammation study. Price pop, melt up from there and we reach escape velocity to the NASDAQ or another exchange. The memory of this will be like a bad dream, except it was real. Anyone holding fast through all this will likely be well rewarded. I can see the probabilities over the horizon and am not budging. True value always wins out in the end.
20
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Gnosis Lab Grand Re-Opening Celebration Gnosis, a modern diagnostic laboratory previously known as Mountain View Medical Laboratory, is excited to announce its grand re-opening at its flagship location. This event signifies a crucial transition for the lab as it seeks to blend years of reliable community service with a fresh identity and enhanced capabilities. Commitment...
Continue Reading
Titan NRG, Inc. Announces Major Propane Contract Secured Titan NRG, Inc. (OTC: TTNN) has a big contract for the 150,000 gallons of propane supply. Given to one of its subsidiaries, this contract represents a significant turning point for the business. Under this contract, propane will be delivered over the next year to a southern Arizona reservation. Crucially in securing...
Continue Reading
Bitcoin Price Experiences a Notable Decline Bitcoin has recently faced a serious downturn, falling to around $93,925 as fears surrounding U.S. interest rate changes and potential government sales of Bitcoin emerged. This has created a concerning environment for cryptocurrency investors, highlighting the volatility of digital assets. Market Sentiment and Economic Shifts...
Continue Reading
Cogitate Partners with One Inc to Transform Digital Payments -Customers Enjoy a Seamless Experience by Unifying All Payment Flows into One Comprehensive Platform- Cogitate, a provider of cloud-native core policy, billing, and claims applications for insurers, is excited to announce its partnership with One Inc, the leading digital payments network specifically for the...
Continue Reading
Alnylam Pharmaceuticals Reaches Record Stock Price Alnylam Pharmaceuticals Inc. has recently made headlines after its stock price reached a remarkable all-time high of $287.88. This surge demonstrates a substantial increase in investor confidence, bolstered by an impressive 1-year change of 71.84% in the company's stock. Known for its groundbreaking work in RNA...
Continue Reading